David F. Bodenstein

Microfluidics in heart-on-a-Chip platforms for cardiovascular drug discovery and cardiotoxicity assessment.

Cardiovascular disease remains the leading cause of death worldwide. However, the limited translational fidelity of traditional preclinical models continues to constrain the development of safer and more effective therapies. Animal studies and static two-dimensional cultures only partially reproduce human cardiac physi...